B
Beatriz Grinsztejn
Researcher at Oswaldo Cruz Foundation
Publications - 464
Citations - 20503
Beatriz Grinsztejn is an academic researcher from Oswaldo Cruz Foundation. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 52, co-authored 367 publications receiving 16945 citations. Previous affiliations of Beatriz Grinsztejn include Emory University & University of North Carolina at Chapel Hill.
Papers
More filters
Journal ArticleDOI
Human Immunodeficiency Virus Encephalopathy: Cognitive and Radiologic Improvement After Antiretroviral Therapy
TL;DR: This case illustrates that it is possible to observe a correlation between cognitive improvement and resolution of neuroimaging abnormalities in patients with HIV dementia.
Journal ArticleDOI
Preferences for PrEP modalities among gay, bisexual, and other men who have sex with men from Brazil, Mexico, and Peru: a cross-sectional study
Thiago S. Torres,Alessandro R. Nascimento,Lara E. Coelho,Kelika A. Konda,E Hamid Vega-Ramirez,Oliver A Elorreaga,Dulce Diaz-Sosa,Brenda Hoagland,Juan V. Guanira,Cristina Pimenta,Marcos Benedetti,Carlos F. Caceres,Valdilea G. Veloso,Beatriz Grinsztejn +13 more
TL;DR: In this article , the authors assess preferences for pre-exposure prophylaxis (PrEP) modalities among MSM from Brazil, Mexico, and Peru, and assess factors associated with each most preferred PrEP modality per country using multivariable logistic regression models.
Journal ArticleDOI
Comparative HIV-1 Proviral Dynamics in Two Individuals That Maintained Viral Replication Control with or without Antiretroviral Therapy following Superinfection
Suwellen S D de Azevedo,Fernanda Heloise Côrtes,Larissa M. Villela,Brenda Hoagland,Beatriz Grinsztejn,Valdilea G. Veloso,Mariza G. Morgado,Gonzalo Bello +7 more
TL;DR: In this paper , the authors performed a longitudinal analysis of the env diversity of PBMC-associated HIV DNA quasispecies in two HIV controllers (EEC09 and VC32) that were superinfected with subtype F1 viruses several years after primoinfection with sub type B viruses.
Posted ContentDOI
Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features
Craig A. Magaret,Allan Decamp,Morgane Rolland,Michal Juraska,Brian D. Williamson,Cindy Molitor,David Benkeser,Alex Luedtke,Lindsay N. Carpp,Hongjun Bai,Bethany L. Dearlove,Alexander L. Greninger,Pavitra Roychoudhury,Jerald C. Sadoff,G. Gray,Sanne Roels,An Vandebosch,Daniel J. Stieh,Mathieu Le Gars,Johan Vingerhoets,Beatriz Grinsztejn,Paul A. Goepfert,Carla Truyers,Ilse Van Dromme,Edith Swann,Mary A. Marovich,Dean Follmann,Kathleen M. Neuzil,Lawrence Corey,Olivier Hyrien,Martin Casapia,M. H. Losso,Susan J. Little,Aditya H. Gaur,Linda-Gail Bekker,Nigel Garrett,Fei Heng,Yanqing Sun,Peter B. Gilbert +38 more
TL;DR: In this paper , SARS-CoV-2 Spike sequences were measured from 484 vaccine and 1,067 placebo recipients who acquired COVID-19 during the ENSEMBLE randomized, placebo-controlled phase 3 trial.
Journal ArticleDOI
Doença pneumocócica invasiva em pessoas vivendo com hiv/aids
Roxana Flores Mamani,Tiago de Assunção,Marcelo Ribeiro de Resende Alves,José Armando de Sousa Moreira,Maria Alexandra Veríssimo Martins da Silva Lourenço,Erica Aparecida dos Santos Ribeiro Silva,Beatriz Grinsztejn,Valdilea G. Veloso,Mário Sérgio Pereira,Sandra Wagner,Cristiane da Cruz Lamas +10 more
TL;DR: Doença pneumocócica invasiva (DPI) is defined as infecção confirmada by isolamento de Streptococcus pneumoniae in sítios estéreis as mentioned in this paper .